Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites
about
InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markersPrevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysisEnvironmental causes of esophageal cancerMore men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population.Molecular and serologic markers of HPV 16 infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma.Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinomaAssociation between human papillomavirus (HPV) and oesophageal squamous cell carcinoma: a meta-analysis.HPV seropositivity joints with susceptibility loci identified in GWASs at apoptosis associated genes to increase the risk of Esophageal Squamous Cell Carcinoma (ESCC)Human papillomavirus in upper digestive tract tumors from three countries.The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population.Genital HPV infection and related lesions in menRole of human papillomavirus and cell cycle-related variants in squamous cell carcinoma of the oropharynx.HPV frequency in penile carcinoma of Mexican patients: important contribution of HPV16 European variant.Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases.Role of human papillomaviruses in esophageal squamous cell carcinoma.Prognostic factors and biomarkers of penile carcinoma.
P2860
Q24606953-FC417798-CBF3-4BC4-BC26-7F6AD48CB2C1Q27027842-4F80C0B7-2831-47AE-8E51-BBEB1329A282Q28388848-34B67E51-34CA-4A48-906E-3A04A2C117BAQ33246180-ECFC5D3C-7D78-4E9B-B954-D5DF576D7A89Q33798618-CA8E1106-EBE6-42CB-8172-FE97D05CE9B1Q34134333-294B4679-9B6C-42AE-847F-83AA2A10E940Q34414666-71381AE3-3198-4C7C-B54F-1348AAADC68EQ34485939-405AB455-AD58-4B7D-88B2-E6EB1D8D2B12Q35638798-9DA3083D-3773-48E8-8840-05C037815DE3Q35677525-D4006129-4680-491C-B330-47F199D9B798Q36389950-620DFAF7-8A8C-4F70-82EE-035A7EBEF126Q36681902-EAE38B40-9EB0-4B7A-BC37-2FC4A437FFC7Q36956232-951E0C8B-FE52-4773-B161-0D3CB5640C96Q37429164-34E6ED7B-611C-4A1D-80C1-C3AEF5E4DD09Q38035068-8CFA3694-6BB2-4DC8-B95E-6E2F0D61FCB3Q53318912-5981A00B-939C-407F-9F4D-9EDA675CA11E
P2860
Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Reactivity to human papillomav ...... e different extragenital sites
@ast
Reactivity to human papillomav ...... e different extragenital sites
@en
type
label
Reactivity to human papillomav ...... e different extragenital sites
@ast
Reactivity to human papillomav ...... e different extragenital sites
@en
prefLabel
Reactivity to human papillomav ...... e different extragenital sites
@ast
Reactivity to human papillomav ...... e different extragenital sites
@en
P2093
P2860
P356
P1476
Reactivity to human papillomav ...... e different extragenital sites
@en
P2093
G J J Van Doornum
J C G M Buning-Kager
J M G Bonfrer
S Horenblas
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600870
P407
P577
2003-04-01T00:00:00Z